Artrya Limited (ASX:AYA)
Australia · Delayed Price · Currency is AUD 4.360
+0.350 (8.73%)
At close: Jan 16, 2026
Artrya Market Cap
Artrya has a market cap or net worth of 689.25 million as of January 16, 2026. Its market cap has increased by 1,453.49% in one year.
Market Cap
689.25M
Enterprise Value
678.54M
Revenue
28.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
4.36
Market Cap Chart
Since November 26, 2021, Artrya's market cap has increased from 119.12M to 689.25M, an increase of 478.61%. That is a compound annual growth rate of 52.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 15, 2026 | 633.92M | -14.86% |
| Dec 31, 2025 | 744.58M | 1,435.71% |
| Dec 31, 2024 | 48.48M | 156.86% |
| Dec 29, 2023 | 18.88M | -39.81% |
| Dec 30, 2022 | 31.36M | -69.23% |
| Dec 31, 2021 | 101.94M | -14.43% |
| Nov 26, 2021 | 119.12M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 84.51B |
| Pro Medicus | 21.56B |
| Cochlear | 17.49B |
| Sonic Healthcare | 11.51B |
| Ramsay Health Care | 8.47B |
| Ansell | 4.84B |
| Telix Pharmaceuticals | 3.78B |
| Mesoblast | 3.48B |